Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
04/2005
04/28/2005CA2540861A1 Novel tetraydrospiro{piperidine-2,7' -pyrrolo[3,2-b]pyridine derivatives and novel indole derivatives useful in the treatment of 5-ht6 receptor -related disorders
04/28/2005CA2540860A1 Preparation of 3-azabicyclo [3.1.0] hexane derivatives
04/28/2005CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use
04/28/2005CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms
04/28/2005CA2539761A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
04/28/2005CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use
04/27/2005EP1525266A1 Site-specific labelling of proteins using cyanine dye reporters
04/27/2005EP1525265A2 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
04/27/2005EP1525197A1 Method for producing highly pure hydroxy indolyl glyoxylic acid amides
04/27/2005EP1525186A1 Inhibitors of hcv ns5b polymerase
04/27/2005EP1525185A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease
04/27/2005EP1525183A1 Inhibitors of hcv ns5b polymerase
04/27/2005EP1423110A4 Cbi analogues of cc-1065 and the duocarmycins
04/27/2005EP1143974B1 Pharmaceutical compositions for alleviating discomfort
04/27/2005EP1011651B1 Method of treating diabetes and related disease states
04/27/2005EP0910572B1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
04/27/2005EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same
04/27/2005CN1610664A 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
04/27/2005CN1610659A Carboxylic acid derivative
04/27/2005CN1610658A Processes for the preparation of glutamic acid compounds and intermediates thereof and novel intermediates used in the processes
04/27/2005CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
04/27/2005CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor
04/27/2005CN1610542A New use for the treatment of gastroesophageal reflux disease
04/27/2005CN1608466A Xylylene imide herbicide
04/27/2005CN1198802C Chalcones having antiproliferactive activity
04/27/2005CN1198801C Indole derivatives
04/27/2005CN1198607C Composition for treating or preventing glomerulopathy
04/27/2005CN1198605C Compound with 5-HT1A activity useful for treating disorders of outer retina
04/26/2005US6884895 Using dihydropyran, triethyl orthoformate and alkyl acrylate
04/26/2005US6884890 Anticancer, antitumor agents, antiarthritic agents
04/26/2005US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent
04/26/2005US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases
04/26/2005US6884803 Phenylalkynes
04/26/2005CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation
04/21/2005WO2005035534A1 Heterocyclic bicyclo ring and heterocyclic tricyclo ring compounds and drugs comprising the same
04/21/2005WO2005035518A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
04/21/2005WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent
04/21/2005WO2005035497A1 Caspase inhibitor comprising 2-alkyl-4-oxobutanoyl group and pharmaceutical composition thereof
04/21/2005WO2005035496A1 Process for the preparation of n-amino substituted heterocyclic compounds
04/21/2005WO2005035495A2 Fibrinogen receptor antagonists and their use
04/21/2005WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element
04/21/2005WO2005034942A1 Animal feed composition
04/21/2005WO2005034941A1 Indoles and azaindoles as antiviral agents
04/21/2005WO2005034939A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
04/21/2005WO2005034848A2 Inhibitors of cathepsin s
04/21/2005US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
04/21/2005US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
04/21/2005US20050085526 Indole derivatives useful for the treatment of diseases
04/21/2005US20050085515 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis
04/21/2005US20050085507 p-phenylethenyl hydroxamates; anticarcinogenic, antitumor, antiproliferative agents; regulating p21 promoter; improved stability
04/21/2005US20050085502 Phenyl-substituted imidazopyridines
04/21/2005US20050085501 Phenyl-substituted imidazopyridines
04/21/2005US20050085487 Heterocyclic compounds
04/21/2005US20050085461 Benzenesulfonamide derivatives
04/21/2005US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease
04/21/2005US20050084711 3, 6-Diphenylcarbazole compound and organic electroluminescent device
04/21/2005CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element
04/21/2005CA2541582A1 Indoles and azaindoles as antiviral agents
04/21/2005CA2541126A1 Animal feed composition
04/21/2005CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005CA2540867A1 Process for the preparation of n-amino substituted heterocyclic compounds
04/21/2005CA2539878A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
04/21/2005CA2539587A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
04/21/2005CA2535930A1 Inhibitors of cathepsin s
04/20/2005EP1524272A1 Growth hormone secretagogues
04/20/2005EP1523528A1 Polymerisable diketopyrrolopyrroles, use of such compounds in colour filters and polymers prepared from these compounds
04/20/2005EP1523474A1 Crystalline forms of imidoalkanpercarboxylic acids
04/20/2005EP1523473A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments
04/20/2005EP1523472A1 Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides
04/20/2005EP1254133B1 Indol-3-yl derivatives and their use as integrin inhibitors
04/20/2005EP1042287B1 Indole derivatives as inhibitors of factor xa
04/20/2005CN1608050A Piperazine derivative
04/20/2005CN1197860C FAB I inhibitors
04/20/2005CN1197855C Organic compound with bi-4-dicyan methylene pyranoid ring and its synthetic method and use
04/20/2005CN1197848C Process for preparing isoindoline
04/19/2005US6881815 Comprises polymerization catalysts; aromatization; elminates need for nitration
04/19/2005US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/19/2005US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
04/14/2005WO2005033104A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
04/14/2005WO2005033080A1 Process for preparing an azabicyclo[3.1.0]hexane compound
04/14/2005WO2005033069A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists
04/14/2005WO2005032594A2 Alkylators linked to polyamides as dna binding agents
04/14/2005WO2005014723A8 Cyanin-type compounds having an alkynyl linker arm
04/14/2005WO2004113291A3 Fluvastatin sodium crystal forms xiv, lxxiii,lxxix, lxxx and lxxxvii, processes for preparing them, compositions containing them and methods of using them
04/14/2005US20050080281 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
04/14/2005US20050080260 Preparation of prodrugs for selective drug delivery
04/14/2005US20050080257 Benzo'fisoindole derivatives with affinity to the ep4 receptor
04/14/2005US20050080141 Amino diols useful in the treatment of alzheimer's disease
04/14/2005US20050080128 Indoles as naaladase inhibitors
04/14/2005US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others
04/14/2005US20050080108 such as (S)-1-ethyl-5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid-[2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]amide; for treatment of obesity and lipid disorders; diabetes
04/14/2005US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators
04/14/2005US20050080020 Hydroxylated indirubin derivatives
04/14/2005US20050079979 Substituted benzoylisoxazoles and the use thereof as herbicides
04/14/2005US20050079541 Immunoadhesin comprising a glycorprotein v1 domain
04/14/2005CA2582437A1 Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
04/14/2005CA2541530A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists
04/14/2005CA2540637A1 Process for preparing an azabicyclo[3.1.0]hexane compound
04/14/2005CA2540502A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas